Eisai remains deeply committed to a patient-centered approach in Alzheimer's care and ensuring LEQEMBI (R) is available to those eligible and living with early AD in Canada. We will continue to pursue ...
The Trump administration has tapped National Institutes of Health (NIH) Director Jay Bhattacharya, MD, PhD, to temporarily oversee the Centers for Disease Control and Prevention (CDC), reports the New ...
Glaukos Corporation (NYSE:GKOS) Q4 2025 Earnings Call Transcript February 17, 2026 Glaukos Corporation misses on earnings ...
ABP News on MSN
CBSE board exams 2026: Class 12 physical education paper today; key pattern, marking scheme & important rules
CBSE Board Class 12 Physical Education Exams 2026: The Central Board of Secondary Education (CBSE) is set to conduct the Class 12 Physical Education examination today, February 18. The paper will take ...
Declaring he was “not scared of a germ” and that “he snorted cocaine off toilet seats,” RFK Jr used Theo Von’s platform to advance mistrust of science and undermine collective public health ...
Aidan Dewar, the CEO of the start-up Telenutrition, and the food blogger Vani Hari spoke on the health benefits of nourishing ...
Given encouraging efficacy and safety, the trial will continue as planned and further updates are anticipated in 1H CY2026 including presentation of data at a major medical conference SYDNEY, ...
Heath Secretary Robert F. Kennedy Jr. promised a renewed focus on the “diagnostic efforts” for tick-borne Lyme disease, describing it on Dec. 15 as an “invisible” illness that he claims has been ...
From custom gene editing to a discovery that could help stop pancreatic cancer before it starts, these advances offer a glimpse at the future of human health. A colorized transmission electron ...
Recent research led by the University of Alberta challenges the belief that mad cow disease is caused only by misfolded proteins—a discovery that sheds new light on the devastating outbreak in the ...
A new FDA approval for a first-in-class drug has vaulted Otsuka into immunoglobulin A nephropathy (IgAN), an increasingly competitive kidney disease field targeted by multiple biopharma companies. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results